Zamaporvint

CAS No. 1900754-56-4

Zamaporvint( —— )

Catalog No. M37117 CAS No. 1900754-56-4

Zamaporvint (RXC004) is a selective, orally active and potent inhibitor of the Wnt pathway that acts on the membrane-bound fatty acyltransferase porcupine to block Wnt ligand palmitoylation, secretion, and pathway activation.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
2MG 132 Get Quote
5MG 202 Get Quote
10MG 330 Get Quote
25MG 635 Get Quote
50MG 1030 Get Quote
500MG Get Quote Get Quote
1G Get Quote Get Quote

Biological Information

  • Product Name
    Zamaporvint
  • Note
    Research use only, not for human use.
  • Brief Description
    Zamaporvint (RXC004) is a selective, orally active and potent inhibitor of the Wnt pathway that acts on the membrane-bound fatty acyltransferase porcupine to block Wnt ligand palmitoylation, secretion, and pathway activation.
  • Description
    Zamaporvint (RXC004) is an orally active and selective inhibitor of Wnt. Zamaporvint targete membrane-bound o-acyltransferase Porcupine and inhibited Wnt ligand palmitoylation, secretion, and pathway activation. Zamaporvint displays a favorable pharmacokinetic profile and shows potent antiproliferative effects in Wnt ligand-dependent colorectal and pancreatic cell lines. Zamaporvint possesses multiple antitumor mechanisms and can be used in cancer research.
  • In Vitro
    Western Blot Analysis Cell Line:L-Wnt5a Concentration:300 nM Incubation Time:48 h Result:Activated the β-catenin-responsive luciferase reporter gene in a concentration-dependent manner, with an IC50 of 64 pmol/L.Apoptosis Analysis Cell Line: L-Wnt5a Concentration:100 nM Incubation Time:24 h Result:Downregulated c-Myc mRNA and reduce the proportion of cells in S-phase, and strongly inhibited expression of the mitosis marker phospho-histone-H3 in cells with upstream aberrations in Wnt pathway components.
  • In Vivo
    Animal Model:SCID-Beige mice were dosed at Translational Drug Discovery with vehicleDosage:1.5 mg/kg or 5 mg/kg; 5 mg/kgAdministration:1.5 mg/kg or 5 mg/kg orally twice daily, or 5 mg/kg RXC004 orally once daily, for 28 daysResult:Reduced in tumor growth, and inhibition of Wnt-responsive gene expression including cMyc, was observed in the Wnt ligand–dependent SNU-1411, AsPC1, and HPAFII models.No effected tumor growth in the Wnt ligand–independent HCT116 xenograft mode.Animal Model:HPAF-II (5 × 106 cells; athymic nude mice), AsPC1 (3 × 106 cells; athymic nude mice), and SNU-1411 (1×107 cells; NOD-SCID mice) were implanted bilaterally, subcutaneously, whereas HCT116 (3 × 106 cells; athymic nude mice) were implanted in a single flank Dosage:Dosing was either 1.5 mg/kg twice daily RXC004 for 7–13 days then once daily for the remainder of study (up to 29 days), or 28 days 1.5 mg/kg twice daily RXC004 for HCT116 Administration:p.o.Result:Demonstrated to inhibit tumor growth and Wnt-responsive gene expressionAnimal Model:B16F10/C57BL/6 syngeneic model was performed at Axis Bioservices. Mouse B16F10 cells (2 × 105) were subcutaneously implanted in flanks of the immunocompetent male C57BL/6 miceDosage:5 mg/kg once daily Administration: p.o.Result: Inhibited tumor growth and improved model survival.Animal Model:CT26/BALB/c syngeneic model was performed at ProQuinase GmbH. Mouse CT26 cells (5 × 105) were subcutaneously implanted in the flanks of the immunocompetent female BALB/c mice Dosage:1.5 or 5 mg/kg (once daily).Administration:p.o.Result:Increased CD8+/regulatory T cell ratio.
  • Synonyms
    ——
  • Pathway
    Others
  • Target
    Other Targets
  • Recptor
    Others
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    1900754-56-4
  • Formula Weight
    439.39
  • Molecular Formula
    C21H16F3N7O
  • Purity
    >98% (HPLC)
  • Solubility
    In Vitro:?DMSO : 125 mg/mL (284.49 mM; Ultrasonic )
  • SMILES
    O=C(NC1=NC=C(C=C1)C=2N=CC=NC2)CN3C=NC(C=4C=CN=C(C4)C(F)(F)F)=C3C
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1. Phillips C, The Wnt Pathway Inhibitor RXC004 Blocks Tumor Growth and Reverses Immune Evasion in Wnt Ligand-dependent Cancer Models. Cancer Res Commun. 2022 Sep 2;2(9):914-928.?
molnova catalog
related products
  • Uridine triphosphate

    Uridine triphosphate increases proliferation of human cancerous pancreatic duct epithelial cells by activating P2Y2 receptor.

  • Phenyl acetate

    Phenyl acetate is the ester of phenol and acetic acid.

  • N-Allylaniline

    N-Allylaniline (AI3-10028) is a basic monomer used in the synthesis of imprinted polymers.